Mucosal vaccines against respiratory syncytial virus

Overview of attention for article published in Current Opinion in Virology, April 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent: 6 patents

Readers on

mendeley: 54 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

FcRn-targeted mucosal vaccination against influenza infections

Grant US-12297233-B2

United States of America

13 May 2025

Compositions and methods for mucosal vaccination against SARS-CoV-2

Grant US-12297232-B2

United States of America

13 May 2025

FcRn-targeted mucosal vaccination against RSV

Grant US-12138306-B2

United States of America

12 Nov 2024

FcRn-targeted mucosal vaccination against RSV

Grant US-11376317-B2

United States of America

05 Jul 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.